Britain's GSK on Tuesday agreed to acquire Nuvalent, a US-based biopharmaceutical company, for $10.6 billion. Under the deal, GSK will pay $124 per share...
Britain’s plans to ban future generations from buying cigarettes will become law this week, ushering in a policy still overshadowed by questions over how...